Video

CURE New Issue Alert: 2020 Hematology Special Edition-1

Here are the latest highlights from the first CURE Hematology Special Edition issue for 2020.

Hi, I’m Jessica Skarzynski for CURE Magazine®, your guide to every stage of the cancer experience.

Here’s a look at what’s inside our 2020 Winter Hematology special issue:

For decades the treatment for acute myeloid leukemia remained the same — intensive chemotherapy. But a wave of new targeted therapies in recent years have expanded options for patients while helping them live longer and better lives. We delve into how oncologists are changing up therapy by Making It Personal.

Next, Eyes are on Immunotherapy for patients with relapsed and resistant diffuse large B-cell lymphoma. Our feature story discusses new treatments beyond tried-and-true chemotherapy.

And, what does an 11-year-old have in common with some of the country’s exceptional oncology health care professionals? Each one is someone’s hero. We share an inside look at CURE’s most recent class of MPN Heroes.

To read these stories and more, visit our publications here and click on the latest CURE cover.

Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit here for more information.

And, as always, thanks for reading.

Related Videos
Image of doctor with brown hair.
Image of man with black hair.
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.